Literature DB >> 12433285

Bacterial infection of osteoblasts induces interleukin-1beta and interleukin-18 transcription but not protein synthesis.

Ian Marriott1, Francis M Hughes, Kenneth L Bost.   

Abstract

A growing body of evidence has shown that bacterially challenged bone-forming osteoblasts are a significant source of an array of cytokines and chemokines that can support immune responses during bone disease. In the present study, Staphylococcus aureus and Salmonella, two common pathogens of bone, were investigated for their ability to induce production of two related inflammatory cytokines, interleukin-1beta (IL-1beta) and IL18, in osteoblasts. Cultured mouse osteoblasts were found to respond rapidly to either bacterial challenge by upregulation in the levels of mRNA encoding both IL-1beta and IL-18. Surprisingly, this mRNA expression did not translate into intracellular accumulation of IL-1beta or IL-18 precursor proteins or secretion of mature cytokines, despite the presence of detectable caspase-1 activity in these cells. These studies demonstrate that although osteoblasts can secrete a number of key proinflammatory mediators in response to bacterial pathogens, IL-1beta and IL-18 are not among this number. We suggest that osteoblasts are an unlikely source of these cytokines during the progression of bacterial infection of bone.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12433285     DOI: 10.1089/107999002760624288

Source DB:  PubMed          Journal:  J Interferon Cytokine Res        ISSN: 1079-9907            Impact factor:   2.607


  11 in total

Review 1.  Osteoblast responses to bacterial pathogens: a previously unappreciated role for bone-forming cells in host defense and disease progression.

Authors:  Ian Marriott
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Substance P Exacerbates the Inflammatory and Pro-osteoclastogenic Responses of Murine Osteoclasts and Osteoblasts to Staphylococcus aureus.

Authors:  M Brittany Johnson; Samantha R Suptela; Sophie E Sipprell; Ian Marriott
Journal:  Inflammation       Date:  2022-08-30       Impact factor: 4.657

Review 3.  Interaction of staphylococci with bone.

Authors:  John A Wright; Sean P Nair
Journal:  Int J Med Microbiol       Date:  2009-11-03       Impact factor: 3.473

4.  Osteoblasts express NLRP3, a nucleotide-binding domain and leucine-rich repeat region containing receptor implicated in bacterially induced cell death.

Authors:  Samuel H McCall; Mahnaz Sahraei; Amy B Young; Charles S Worley; Joseph A Duncan; Jenny Pan-Yun Ting; Ian Marriott
Journal:  J Bone Miner Res       Date:  2008-01       Impact factor: 6.741

Review 5.  Apoptosis-associated uncoupling of bone formation and resorption in osteomyelitis.

Authors:  Ian Marriott
Journal:  Front Cell Infect Microbiol       Date:  2013-12-19       Impact factor: 5.293

6.  NLRP3 promotes autophagy of urate crystals phagocytized by human osteoblasts.

Authors:  Isabelle Allaeys; François Marceau; Patrice E Poubelle
Journal:  Arthritis Res Ther       Date:  2013-11-01       Impact factor: 5.156

Review 7.  Inflammasomes in Alveolar Bone Loss.

Authors:  Yang Li; Junqi Ling; Qianzhou Jiang
Journal:  Front Immunol       Date:  2021-06-09       Impact factor: 7.561

Review 8.  Staphylococcus aureus vs. Osteoblast: Relationship and Consequences in Osteomyelitis.

Authors:  Jérôme Josse; Frédéric Velard; Sophie C Gangloff
Journal:  Front Cell Infect Microbiol       Date:  2015-11-26       Impact factor: 5.293

9.  Inhibition of Methicillin-resistant Staphylococcus aureus-induced cytokines mRNA production in human bone marrow derived mesenchymal stem cells by 1,25-dihydroxyvitamin D3.

Authors:  Aparna Maiti; William A Jiranek
Journal:  BMC Cell Biol       Date:  2014-03-25       Impact factor: 4.241

10.  Impact of the Maturation of Human Primary Bone-Forming Cells on Their Behavior in Acute or Persistent Staphylococcus aureus Infection Models.

Authors:  Jérôme Josse; Christine Guillaume; Camille Bour; Flora Lemaire; Céline Mongaret; Florence Draux; Frédéric Velard; Sophie C Gangloff
Journal:  Front Cell Infect Microbiol       Date:  2016-06-21       Impact factor: 5.293

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.